The purpose of the study was the most adequate modeling of multiple sclerosis in the form of autoimmune allergic encephalomyelitis for further use in the study of experimental equivalents of neurodegenerative conditions. Materials and methods. The article highlights the results of the formation of experimental allergic encephalomyelitis, for the induction of which homologous brain homogenates were used, which in terms of encephalitogenicity ranks first among other drugs (homologous, heterogeneous brain and spinal cord homogenates). An encephalitogenic mixture was injected into the connective tissue of the base of the animal's tail at the rate of 0.1 ml per 100 g of body weight. Results and discussion. Experimental allergic encephalomyelitis reproducible by intradermal administration of a homogenate of the brain, spinal cord and peripheral nerves with a Freund's stimulator belongs to a true autoimmune disease of the nervous system and is an experimentally reproducible model of multiple sclerosis. According to the experimental data obtained, the state of the animals showed that the rats of the experimental group lost body weight, had a number of pathological neurological symptoms, which manifested on average from 10-12 days. The increase in symptoms continued for an average of 7 days and was not very stable. Experimental animals had paresis, manifestations of ataxia, walking disorders and urinary and fecal incontinence, lethargy, which corresponded to 1-2 degrees of the rating scale in 13 animals. In 7 rats, paresis of the hind limbs and loss of tail tone were expressed (grade 3). Most of the rats recovered spontaneously within 6-8 days after the onset of clinical manifestations (18-20 days after immunization). According to the requirements of the experiment, during the paralytic stage, the rats had free access to food and water. In addition, our experimental studies on the formation of experimental allergic encephalomyelitis were confirmed morphologically using electron microscopy. Conclusion. The use of this technique for the formation of experimental allergic encephalomyelitis made it possible to obtain a simulated pathological state of multiple sclerosis in the form of experimental allergic encephalomyelitis and can be used in further studies to identify the corresponding patterns, the degree and nature of changes in the immune and nervous systems of the body during the reproduction of an experimental pathological state. The data obtained can serve as a basis for further studies of drugs and their combinations in order to improve and rationalize the pharmacotherapy of multiple sclerosis
Read full abstract